Pacific Shuanglin Bio-pharmacy Co., Ltd. (SHE:000403)
China
· Delayed Price · Currency is CNY 12.17
-0.11 (-0.90%)
Apr 29, 2026, 3:04 PM CST
SHE:000403 Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Apr '26 Apr 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | 2021 - 2017 |
| Market Capitalization | 11,566 | 13,011 | 15,448 | 19,957 | 16,669 | 20,540 | Upgrade
|
| Market Cap Growth | -27.72% | -15.77% | -22.60% | 19.73% | -18.85% | 9.77% | Upgrade
|
| Enterprise Value | 11,647 | 12,801 | 14,283 | 18,990 | 15,725 | 19,928 | Upgrade
|
| Last Close Price | 12.17 | 13.69 | 16.00 | 20.33 | 16.91 | 20.78 | Upgrade
|
| PE Ratio | 34.20 | 31.03 | 20.73 | 32.60 | 28.39 | 52.52 | Upgrade
|
| Forward PE | 11.46 | 11.50 | 16.77 | 30.96 | 20.90 | 36.40 | Upgrade
|
| PS Ratio | 4.45 | 4.94 | 5.82 | 8.57 | 6.93 | 10.42 | Upgrade
|
| PB Ratio | 1.43 | 1.61 | 1.95 | 2.69 | 2.43 | 3.25 | Upgrade
|
| P/TBV Ratio | 2.15 | 2.43 | 3.02 | 4.34 | 4.11 | 5.85 | Upgrade
|
| P/FCF Ratio | - | - | - | 66.14 | 114.50 | 250.30 | Upgrade
|
| P/OCF Ratio | - | - | 48.01 | 29.39 | 31.80 | 50.32 | Upgrade
|
| EV/Sales Ratio | 4.48 | 4.86 | 5.38 | 8.15 | 6.54 | 10.11 | Upgrade
|
| EV/EBITDA Ratio | 17.55 | 17.69 | 15.63 | 24.64 | 22.32 | 37.04 | Upgrade
|
| EV/EBIT Ratio | 22.55 | 21.83 | 18.01 | 29.97 | 26.79 | 46.32 | Upgrade
|
| EV/FCF Ratio | -21.38 | - | - | 62.94 | 108.02 | 242.85 | Upgrade
|
| Debt / Equity Ratio | 0.10 | 0.10 | 0.08 | 0.07 | 0.05 | 0.02 | Upgrade
|
| Debt / EBITDA Ratio | 1.19 | 1.11 | 0.71 | 0.64 | 0.52 | 0.26 | Upgrade
|
| Debt / FCF Ratio | - | - | - | 1.64 | 2.57 | 1.72 | Upgrade
|
| Net Debt / Equity Ratio | 0.01 | -0.03 | -0.12 | -0.18 | -0.15 | -0.15 | Upgrade
|
| Net Debt / EBITDA Ratio | 0.13 | -0.29 | -1.04 | -1.76 | -1.49 | -1.82 | Upgrade
|
| Net Debt / FCF Ratio | -0.16 | 0.39 | 4.77 | -4.50 | -7.21 | -11.92 | Upgrade
|
| Asset Turnover | 0.28 | 0.28 | 0.30 | 0.28 | 0.32 | 0.45 | Upgrade
|
| Inventory Turnover | 0.97 | 1.10 | 1.26 | 1.47 | 1.69 | 1.80 | Upgrade
|
| Quick Ratio | 1.59 | 1.88 | 2.42 | 2.70 | 2.46 | 2.67 | Upgrade
|
| Current Ratio | 3.37 | 3.30 | 3.74 | 3.72 | 3.18 | 3.85 | Upgrade
|
| Return on Equity (ROE) | 4.39% | 5.24% | 9.71% | 8.56% | 8.91% | 10.73% | Upgrade
|
| Return on Assets (ROA) | 3.48% | 3.92% | 5.55% | 4.77% | 4.87% | 6.13% | Upgrade
|
| Return on Invested Capital (ROIC) | 5.33% | 6.63% | 10.63% | 9.48% | 9.36% | 11.15% | Upgrade
|
| Return on Capital Employed (ROCE) | 6.20% | 7.00% | 9.60% | 8.20% | 8.40% | 6.70% | Upgrade
|
| Earnings Yield | 3.05% | 3.22% | 4.83% | 3.07% | 3.52% | 1.90% | Upgrade
|
| FCF Yield | -4.71% | -4.22% | -1.29% | 1.51% | 0.87% | 0.40% | Upgrade
|
| Dividend Yield | 3.13% | - | 2.40% | 0.76% | 0.36% | 0.21% | Upgrade
|
| Payout Ratio | 77.72% | 65.30% | 35.50% | 10.91% | 8.46% | 3.08% | Upgrade
|
| Buyback Yield / Dilution | -2.33% | -0.31% | -0.28% | 0.33% | -3.38% | -44.25% | Upgrade
|
| Total Shareholder Return | 0.82% | -0.31% | 2.12% | 1.08% | -3.02% | -44.04% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.